Empower Clinics - CEO, Steven McAuley.
CEO, Steven McAuley.
Source: Empower Clinics.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Empower Clinics signed a partnership agreement with Alp Medtech AG
  • Alp Medtech is a European medical device company specializing in the distribution and manufacturing of invitro diagnostic tests and medical devices
  • Empower has the rights to distribute Atlas products in the US, Canada, Mexico, Central America, Australia, New Zealand
  • Empower to provide clinical study services for FDA approval of Atlas products
  • Empower to support Atlas and its partners to set up future USA manufacturing
  • Empower is a healthcare company with multi-disciplinary clinics, an at-home medical testing device company and state-of-the-art medical diagnostics laboratories
  • Empower Clinics Inc. (EPW) is up 20 per cent on the day, trading at C$0.03 per share at 2:15 pm ET

Empower Clinics (EPW) has signed a partnership agreement with Alp Medtech AG (ALP) – the authorized representative of Atlas Medical Gmbh.

Atlas is a European medical device company specializing in the distribution and manufacturing of invitro diagnostic tests and medical devices.

Steven McAuley, Chairman and CEO of Empower Clinics, commented on the agreement.

“Our partnership with Atlas will help accelerate our immediate growth plans in the U.S. market. Together, we can generate short-term revenues as a number of Atlas products are already FDA-approved and only require sales and marketing support from Empower and our subsidiaries. Our longer-term collaboration can also drive further growth in the U.S. as we secure U.S. FDA approvals for more Atlas products by leveraging our diagnostics laboratory and medical team for clinical studies.”

Dr. Raed Shadfan, PhD., founder of Atlas, added,

“We are excited to enter the U.S. market in partnership with Empower. Atlas products and services have already seen success in Europe, Asia, and Africa. Together with Empower, we look forward to growing our global presence and entering the massive U.S. market. Many of our products are already FDA-approved, and we were simply waiting for a partner like Empower to help us successfully expand our global reach. Combining our global manufacturing and distribution expertise with Empower’s U.S. talent and laboratory presence is a synergy that will benefit more Americans to access affordable and convenient medical diagnostic devices.”

Empower is an integrated healthcare company with multi-disciplinary clinics, an at-home medical testing device company and state-of-the-art medical diagnostics laboratories. 

Atlas Medical supplies a range of diagnostic products in the fields of serology, hematology, microbiology, immunology, histopathology, and biochemistry. 

Empower Clinics Inc. (EPW) is up 20 per cent on the day, trading at C$0.03 per share at 2:15 pm ET.


More From The Market Herald

" @ the Bell: Markets tumble amid rate worries

Canada’s main stock index was weighed down on Monday by commodity-linked and financial stocks. The telecom and utilities sectors posted some gains.
Dolly Varden Silver Corporation - President & CEO, Shawn Khunkhun.

" Dolly Varden Silver (TSXV:DV) reports highest-grade silver assay found so far on the Kitsault Valley Property

Dolly Varden Silver Corporation (DV) discovered the highest-grade silver assay found so far on the Kitsault Valley Property.

" Black Tusk Resources (CSE:TUSK) acquiring PegaLith Project

Black Tusk Resources (TUSK) has signed a $361,000 share purchase agreement to acquire 1396427 BC Ltd.

" Deep South Resources (TSXV:DSM) closes oversubscribed non-brokered private placement

Deep-South Resources (DSM) has closed the final tranche of an oversubscribed, non-brokered private placement for gross proceeds of $490,000.